Atlantic International Corp.
HealthcareNASDAQ:ATLN · NASDAQ Global Market
-$0.10 today
Vol 0.36M · Avg 0.44M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-75.41%
Period High
$5.05
Period Low
$0.60
Latest
$0.60
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Cybin Inc.
CYBN
$413.02M
Prenetics Global Limited
NASDAQ:PRE
$367.72M
Anteris Technologies Global Corp.
NASDAQ:AVR
$336.61M
Nkarta, Inc.
NASDAQ:NKTX
$204.62M
Insight Molecular Diagnostics Inc.
NASDAQ:IMDX
$150.58M
Milestone Pharmaceuticals Inc.
NASDAQ:MIST
$109.08M
PepGen Inc.
NASDAQ:PEPG
$101.68M
Neuronetics, Inc.
NASDAQ:STIM
$92.55M
Cassava Sciences, Inc.
SAVA
$63.77M
China SXT Pharmaceuticals, Inc.
SXTC
$1.99M
What is the latest ATLN filing?
The latest filing shown is 424B3 dated May 27, 2026.
How many recent filings does ATLN have?
Intrinsic Alpha currently shows 20 recent filings for ATLN.
Explore More
Continue the stock analysis
Jump to another research area for this company.